MCF Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.5K | Hold |
364
| – | – | ﹤0.01% | 490 |
|
|
2025
Q1 | $26.4K | Sell |
364
-24
| -6% | -$1.74K | ﹤0.01% | 495 |
|
|
2024
Q4 | $28.7K | Sell |
388
-3
| -0.8% | -$222 | ﹤0.01% | 484 |
|
|
2024
Q3 | $25.8K | Sell |
391
-67
| -15% | -$4.42K | ﹤0.01% | 495 |
|
|
2024
Q2 | $42.3K | Buy |
458
+58
| +15% | +$5.36K | ﹤0.01% | 414 |
|
|
2024
Q1 | $38.2K | Buy |
400
+3
| +0.8% | +$287 | ﹤0.01% | 420 |
|
|
2023
Q4 | $30.3K | Sell |
397
-14
| -3% | -$1.07K | ﹤0.01% | 445 |
|
|
2023
Q3 | $28.5K | Hold |
411
| – | – | ﹤0.01% | 434 |
|
|
2023
Q2 | $38.8K | Hold |
411
| – | – | ﹤0.01% | 392 |
|
|
2023
Q1 | $34K | Buy |
411
+264
| +180% | +$21.8K | ﹤0.01% | 409 |
|
|
2022
Q4 | $11K | Buy |
147
+14
| +11% | +$1.05K | ﹤0.01% | 523 |
|
|
2022
Q3 | $11K | Hold |
133
| – | – | ﹤0.01% | 538 |
|
|
2022
Q2 | $13K | Hold |
133
| – | – | ﹤0.01% | 487 |
|
|
2022
Q1 | $16K | Buy |
+133
| New | +$16K | ﹤0.01% | 481 |
|
|
2021
Q4 | – | Sell |
-133
| Closed | -$15K | – | 246 |
|
|
2021
Q3 | $15K | Buy |
133
+33
| +33% | +$3.72K | ﹤0.01% | 442 |
|
|
2021
Q2 | $10K | Hold |
100
| – | – | ﹤0.01% | 447 |
|
|
2021
Q1 | $8K | Hold |
100
| – | – | ﹤0.01% | 430 |
|
|
2020
Q4 | $9K | Hold |
100
| – | – | ﹤0.01% | 389 |
|
|
2020
Q3 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 395 |
|